ONMD ONEMEDNET CORP

OneMedNet Joins ClinEco Community of Clinical Research Industry Members

OneMedNet Joins ClinEco Community of Clinical Research Industry Members

~ Validates OneMedNet’s Regulatory Grade Real World Data Platform Among the Clinical Trial Eco-System ~

MINNEAPOLIS, April 30, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet”), the leading curator of precision curated regulatory-grade Real World Data (“RWD”), today announced that it has accepted an invitation to join ClinEco Inc., a connectivity platform and community environment, which improves access and expands distribution while promoting streamlined partner interactions and accelerated clinical innovation.

“We are excited to be invited to join this vibrant clinical trial community, which validates that our Real World Data platform is a trusted source for precision regulatory grade clinical data (RWD),” stated Aaron Green, OneMedNet President and CEO. “The effective utilization of Real World Data in clinical research is rapidly increasing and, as with many high growth market segments, there is a need for all participants to connect and grow together. We believe ClinEco will be a valuable platform for us to both educate, and efficiently provide specific and precise high quality RWD driving insights for Life Science members.”

ClinEco (short for Clinical Ecosystem) is the world’s first B2B market network for clinical trials, uniting sponsors, CROs, service providers, and sites on the world’s largest clinical trial marketplace enabling members to explore, engage, and exchange capabilities with their own ecosystem of partners. ClinEco was designed by the creators of SCOPE (Summit for Clinical Ops Executives).

About OneMedNet Corporation

Founded in 2009, OneMedNet provides innovative solutions that unlock the significant value contained within the clinical data repositories of healthcare providers. OneMedNet's robust iRWD™ platform provides secure, comprehensive management of diverse clinical data types, including electronic health records (EHR), laboratory results, medical imaging data. Employing its proven OneMedNet iRWD platform, OneMedNet securely de-identifies, searches, and curates a data archive locally, bringing a wealth of internal and third-party research opportunities to healthcare providers. By leveraging this extensive federated provider network, together with industry leading technology and in-house clinical expertise, OneMedNet successfully meets the most rigorous RWD Life Science requirements.

The OneMedNet iRWD network consists of 290+ facilities from leading healthcare systems and providers. Our commitment to growing our platform to provide near real time real-world data translates into healthcare innovations, setting new standards in patient care and advancing the future of medicine. For more information about OneMedNet Corporation, please visit .

About ClinEco

ClinEco unites sponsors, CROs, service providers, and sites on the world's first B2B clinical trial marketplace, empowering all to expand clinical partnerships. By creating a platform where all research stakeholders can explore, engage, and exchange capabilities with an ecosystem of partners, ClinEco accelerates the process of vendor selection, leading to faster, more efficient clinical trials. ClinEco is a Cambridge Healthtech Institute Company. Learn more about the ClinEco community by visiting .

Company Contact:

OneMedNet Corporation

Michael Wong, Director of Marketing

Phone: 800.918.7189

Email:

SOURCE: ONEMEDNET CORPORATION



EN
30/04/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on ONEMEDNET CORP

 PRESS RELEASE

OneMedNet Expands Multiple Revenue-Delivering Projects Under Evergreen...

OneMedNet Expands Multiple Revenue-Delivering Projects Under Evergreen Agreement With Top Medical Device Leader MINNEAPOLIS, Aug. 25, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq:ONMD) (“OneMedNet,” the “Company,” “we,” “us” or “our”), a leader in AI-powered Real-World Data (RWD), announces significant adoption by one of the world’s top five medical device leaders. Renowned for its cutting-edge diagnostic imaging systems, clinical software, and digital health solutions, this global innovator is recognized for advancing precision medicine and improving patient outcomes worldwide....

 PRESS RELEASE

OneMedNet Adds 2.7M Annual Cardiovascular Studies, Expanding Network

OneMedNet Adds 2.7M Annual Cardiovascular Studies, Expanding Network MINNEAPOLIS, Aug. 20, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq:ONMD) (“OneMedNet” or the “Company”), a leader in AI-powered Real-World Data (RWD), announced the addition of 85 cardiovascular centers and data sources, expanding its Cardiovascular network thereby positioning OneMedNet as one of the largest providers for Cardiovascular Real-World data. Cardiovascular diseases (CVDs) remain the world’s leading cause of death, responsible for approximately 19.8 million deaths in 2022, accounting for roughly 32%...

 PRESS RELEASE

OneMedNet initiates new Subscription Revenue model in partnership with...

OneMedNet initiates new Subscription Revenue model in partnership with Circle CVI MINNEAPOLIS, Aug. 18, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq:ONMD) (“OneMedNet” or the “Company”), a leader in AI-powered Real-World Data (RWD) announced a long-term strategic partnership with Circle Cardiovascular Imaging Inc. (Circle CVI), a global leader in advanced cardiovascular imaging solutions. The collaboration reflects Circle CVI’s commitment to leveraging trusted, high-quality data to drive innovation in cardiac diagnostics, treatment planning, and AI model development with data be...

 PRESS RELEASE

OneMedNet Reports 80% Reduction in Debt Enabling Focus On Growth

OneMedNet Reports 80% Reduction in Debt Enabling Focus On Growth MINNEAPOLIS, Aug. 14, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq:ONMD) (“OneMedNet,” the “Company,” “we,” “us” or “our”), a leader in AI-powered Real-World Data (RWD), announced its financial results for the second quarter ended June 30, 2025, including its significantly improved balance sheet. Second Quarter and First Half 2025 Financial Highlights Improved Balance Sheet: Due to the combination of debt conversions, vendor repayments, and highly discounted debt settlements, total liabilities have be...

 PRESS RELEASE

OneMedNet Reports Over 25% Expansion of iRWD™ Network, Encompassing Cl...

OneMedNet Reports Over 25% Expansion of iRWD™ Network, Encompassing Clinical Data alongside Aggregate Health Economics and Social Determinant Insights from 5 Billion Administrative Records, Fueling Growth in AI-Powered Healthcare Data Over 1,750 provider sites and access to 136 million clinical exams positions OneMedNet for accelerated revenue and market penetration MINNEAPOLIS, Aug. 04, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq:ONMD) (“OneMedNet” or the “Company”), a leader in AI-powered Real-World Data (RWD) announced today a greater than 25% expansion of its proprietary ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch